VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,606,957 | -37.9% | 104,756 | -3.7% | 0.74% | -37.2% |
| Q2 2023 | $2,587,519 | +7.2% | 108,765 | +14.6% | 1.18% | -39.8% |
| Q1 2023 | $2,414,485 | -17.3% | 94,909 | -5.1% | 1.97% | +13.4% |
| Q4 2022 | $2,920,474 | +39.1% | 99,982 | -2.3% | 1.73% | +44.6% |
| Q3 2022 | $2,100,000 | +303.1% | 102,372 | +127.3% | 1.20% | +280.6% |
| Q2 2022 | $521,000 | -42.6% | 45,039 | -8.2% | 0.32% | -45.4% |
| Q1 2022 | $907,000 | – | 49,065 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 680,768 | $11,376,000 | 2.18% |
| COMMODORE CAPITAL LP | 185,781 | $3,104,000 | 1.24% |
| Ghost Tree Capital, LLC | 300,000 | $5,013,000 | 1.18% |
| Logos Global Management LP | 550,000 | $9,191,000 | 0.90% |
| Atlas Venture Advisors, Inc. | 209,505 | $3,501,000 | 0.65% |
| BVF INC/IL | 463,504 | $7,745,000 | 0.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 27,586 | $461,000 | 0.25% |
| Fairmount Funds Management LLC | 35,092 | $581,000 | 0.24% |
| Soleus Capital Management, L.P. | 67,685 | $1,131,000 | 0.20% |
| Cormorant Asset Management, LP | 459,144 | $7,672,000 | 0.17% |